NLARx Newsletter Header
NLARx News
January 16, 2008
In This Issue
NLARx in the News
Outrage of the Week
In the States
Advertising and Marketing
Confidentiality
Drug Prices
Pharma Watch
Medicare
Medicaid
Safety & Clinical Trials
Fraud & Abuse
Quick Links
Join Our Mailing List
NLARx in the News
Last Chance to Sign Up for Our Meeting Jan. 25 in Washington, D.C. More
D.C. Council Passes SafeRx Act; Requires Licensing of Pharma Detailers More
Big Pharma's "Right" to Find Out What Doctors Are Prescribing More
Outrage of the Week 
Did Industry Intentionally Hold Off Reporting Negative Clinical Trial Results for 2 Years While Sales Continued?
Study Deals Setback to Cholesterol Drug More
Study Reveals Doubt on Drug for Cholesterol More
In the States
NEW HAMPSHIRE: NLARx Defends Datamining Law in Federal Appeals Court More
DISTRICT OF COLUMBIA: Academic Detailing, Drug Rep Licensing Law Enacted More
Catania Statement on Study Showing Drug Samples Don't Benefit Poor More
MARYLAND: Delegate Montgomery Introduces Datamining Bill More
VERMONT: U.S. Solicitor General Says FDA Approval of Drug Labeling Preempts State Law More
CALIFORNIA: Appeals Panel Supports Healthy San Francisco on ERISA Claim More
OREGON: Enrollment in Rx Discount Program Grows By Leaps and Bounds More
MAINE: NLARx Director Treat Addresses Doctors on Datamining, Marketing Issues More
FLORIDA: Governor Pitches Limited Drug Plan More
WEST VIRGINIA: Lawmakers Want Drug Spending Data More
Advertising and Marketing
Analysis Says U.S. Pharmaceutical Promotion Expense Doubles That of R&D More
Drug Ties That Bind More
Insured, Wealthier Patients More Likely To Receive No-Cost Prescription Drug Samples From Physicians, According to Study More
Confidentiality
Philadelphia Inquirer Examines Software To Compile Transcripts of Physician-Patient Interactions More
Drug Prices
Patients Use More Drugs for Chronic Ills If Copays Cut More
U.K. National Health Service Proposing 10% Cut for Prescription Drug Prices More
Medicaid-Level Pricing of Some Drugs Could Cut Costs for Medicare, Study Says More

Pharma Watch
Center for Responsive Politics Publishes Political Spending by Big Pharma More
FDA Approves Fewest New U.S. Drugs Since '83  More
Alabama Announces $6.75 Million Settlement with Two Pharmaceutical Companies More
Under Attack for Addictive Pain Killer, Perdue Pharma Turned to Giuliani for Help More
Medicare
CMS Regulation Would Eliminate Premiums for Some Low-Income Medicare Drug Plan Beneficiaries More
Study: Medicare Helps Push Drug Spending Up More
CMS Regulation Aimed at Boosting Drug Coverage for Poorer Seniors as Analysis Finds Prices Higher More
Insurers Whack Elderly to Celebrate New Year More
AARP Plans Accused of Siphoning Money from Medicare More
Medicaid
U.S. Curtailing Efforts by States to Expand Medicaid Rolls More
Safety & Clinical Trials
The Medicated Child: PBS Takes On Pharma More
FDA Amendments Act: Clinical Trial Data Bank Certification Goes Into Effect More
Study Finds Many Physicians Prescribe Placebos to Patients More
FDA To Review New Data on Risks Associated With Anemia Drugs More
Fraud & Abuse
Mass. Company Pays Hefty Penalty After Admitting to Violations of FDC Act and Obstructing Proceeding More
Artificial Limbs, But Real Medicare Fraud More